中东和非洲药代动力学服务市场预测至 2031 年 - 区域分析 - 按药物类型（小分子、大分子和疫苗）、服务类型（临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等）、治疗应用（肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等）和最终用户（制药和生物技术公司、合同研究组织等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)

No. of Pages: 88    |    Report Code: BMIRE00030918    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Pharmacokinetics Services Market
Free Sample Buy Now
2023 年中东和非洲药代动力学服务市场价值为 4597 万美元，预计到 2031 年将达到 7432 万美元；预计 2023 年至 2031 年的复合年增长率为 6.2%。

慢性病和传染病患病率上升促进了中东和非洲药代动力学服务市场的发展

糖尿病、癌症和自身免疫性疾病等慢性病的患病率不断上升，成为世界各地药物开发努力的主要推动力。根据世界卫生组织 (WHO) 2024 年的数据，全球约有 4.22 亿人患有糖尿病，这些病例大多发生在中低收入国家，每年造成约 150 万人死亡。制药公司在开发治疗各种疾病的药物方面处于领先地位。药代动力学研究通过分析人体内的吸收、分布、代谢和消除 (ADME) 过程，对于了解这些药物在患者体内的行为至关重要。药物进入体循环的吸收会影响药物到达作用部位（例如血浆）的速度和浓度。药物在体内的分布模式因其生化特性和身体生理学而异。代谢涉及身体将药物加工成后续化合物的过程。此步骤有助于将药物转化为水溶性物质，使其适合肾脏清除。代谢对于将可待因等前体药物转化为活性代谢物也很重要。药物从体内排泄主要由肾脏控制；然而，在某些情况下，药物也可能通过肺、皮肤或胃肠道排泄。 ADME 动力学定义了药物在体内的生物利用度，药物的维持剂量是根据其清除时间（所需血浆浓度除以生物利用度）计算的。了解清除率可让医生计算出适当的给药率。

药代动力学研究侧重于优化研究对象的药物剂量方案，以了解药物的有效性和安全性。这些研究对于确保为长期治疗而开发的药物的安全性至关重要，有助于评估药物制剂在慢性病管理中的适用性和稳定性。因此，慢性病和传染病负担的不断加重凸显了药代动力学研究对于开发安全有效的个性化治疗的重要性。

中东和非洲药代动力学服务市场概览

南非占中东和非洲药代动力学服务市场的最大份额。南非政府已开始提供投资激励措施，采取措施保护知识产权 (IP)，简化税收规则，并实施更好的监管政策以吸引外国投资，最终培育该国的临床试验格局。2019 年，共有约 6267 万美元（10 亿南非兰特）投资于即将进行和正在进行的试验。2016-2021 年期间，在南非运营的创新型跨国制药公司花费约 1.8 亿美元（29.5 亿南非兰特）用于支持临床研究活动，重点是解决该国未满足的医疗需求。

南非是非洲大陆经济最发达的国家，它为临床试验建立了更好的监管标准。较低的临床研究运营成本和较小的诉讼风险使南非成为外国公司外包其临床研究运营的有吸引力的选择。此外，由于该国的高招募率和改善的监管环境，试验的数量一直在增加。南非从创新制药公司获得大量赞助，用于开展临床研究，且没有放缓的迹象。因此，不断发展的临床研究行业促进了该国药代动力学服务市场的增长。

中东和非洲药代动力学服务市场收入及预测至 2031 年（百万美元）

中东和非洲药代动力学服务市场细分

中东和非洲药代动力学服务市场分为药物类型、服务类型、治疗应用、最终用户和国家。

根据药物类型，中东和非洲药代动力学服务市场分为小分子、大分子和疫苗。小分子细分市场在 2023 年占据最大市场份额。

就服务类型而言，中东和非洲药代动力学服务市场分为临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等。临床前 ADME 和人体研究细分市场在 2023 年占据最大市场份额。

按治疗应用，中东和非洲药代动力学服务市场细分为肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等。肿瘤学细分市场在 2023 年占据最大市场份额。

按最终用户划分，中东和非洲药代动力学服务市场细分为制药和生物技术公司、合同研究组织等。合同研究组织部门在 2023 年占据了最大的市场份额。

按国家/地区划分，中东和非洲药代动力学服务市场分为南非、沙特阿拉伯、阿联酋和中东和非洲其他地区。2023 年，南非占据了中东和非洲药代动力学服务市场份额的主导地位。

Charles River Laboratories International Inc；Eurofins Scientific SE；Certara Inc.；Parexel International Corp；Thermo Fisher Scientific Inc.；Allucent；PACIFIC BIOLABS；和 SGS SA 是中东和非洲药代动力学服务市场中的领先公司。

Middle East & Africa Pharmacokinetics Services Strategic Insights

Strategic insights for Middle East & Africa Pharmacokinetics Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-pharmacokinetics-services-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Pharmacokinetics Services Report Scope

Report Attribute Details
Market size in 2023 US$ 45.97 Million
Market Size by 2031 US$ 74.32 Million
Global CAGR (2023 - 2031) 6.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类型
  • 小分子
  • 大分子
  • 疫苗
By 服务类型
  • 临床前 ADME 和人体研究
  • PK/PD 分析和报告
  • 剂量模拟
  • 风险分析
By 最终用户
  • 制药和生物技术公司
  • 合同研究组织
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Allucent
  • Certara Inc.
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • PACIFIC BIOLABS
  • Parexel International Corp
  • SGS SA
  • Thermo Fisher Scientific Inc.
    		•
    Get more information on this report

    Middle East & Africa Pharmacokinetics Services Regional Insights

    The regional scope of Middle East & Africa Pharmacokinetics Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-pharmacokinetics-services-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Pharmacokinetics Services Market

    1. Allucent
    2. Certara Inc.
    3. Charles River Laboratories International Inc
    4. Eurofins Scientific SE
    5. PACIFIC BIOLABS
    6. Parexel International Corp
    7. SGS SA
    8. Thermo Fisher Scientific Inc.
    Frequently Asked Questions
    How big is the Middle East & Africa Pharmacokinetics Services Market?

    The Middle East & Africa Pharmacokinetics Services Market is valued at US$ 45.97 Million in 2023, it is projected to reach US$ 74.32 Million by 2031.

    What is the CAGR for Middle East & Africa Pharmacokinetics Services Market by (2023 - 2031)?

    As per our report Middle East & Africa Pharmacokinetics Services Market, the market size is valued at US$ 45.97 Million in 2023, projecting it to reach US$ 74.32 Million by 2031. This translates to a CAGR of approximately 6.2% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Pharmacokinetics Services Market report typically cover these key segments-

  • 药物类型 (小分子, 大分子, 疫苗)
  • 服务类型 (临床前 ADME 和人体研究, PK/PD 分析和报告, 剂量模拟, 风险分析)
  • 最终用户 (制药和生物技术公司, 合同研究组织)

    • What is the historic period, base year, and forecast period taken for Middle East & Africa Pharmacokinetics Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Pharmacokinetics Services Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Middle East & Africa Pharmacokinetics Services Market?

    The Middle East & Africa Pharmacokinetics Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Allucent
  • Certara Inc.
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • PACIFIC BIOLABS
  • Parexel International Corp
  • SGS SA
  • Thermo Fisher Scientific Inc.
    • Who should buy this report?

    The Middle East & Africa Pharmacokinetics Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Pharmacokinetics Services Market value chain can benefit from the information contained in a comprehensive market report.

    middle-east-and-africa-pharmacokinetics-services-market